Provigil Buyers Ask Judge To Reconsider Class Cert. Denial
Consumers and health plans who filed pay-for-delay litigation over Cephalon Inc.'s narcolepsy drug Provigil asked a Pennsylvania federal judge Thursday to reconsider his decision not to certify them as a class,...To view the full article, register now.
Already a subscriber? Click here to view full article